Description

CJC-1295 + Ipamorelin Overview

CJC-1295 + Ipamorelin is a dual-peptide combination studied for its synergistic role in supporting growth hormone release and hormonal regulation. This pairing combines a growth hormone-releasing hormone (GHRH) analog with a growth hormone-releasing peptide (GHRP), creating a complementary system for stimulating natural growth hormone production.

It is commonly explored in research involving recovery, body composition, and performance optimization.

Key Research Focus

• Synergistic growth hormone release and regulation
• Support for recovery and body composition
• Hormonal optimization and performance enhancement

Mechanism of Action

CJC-1295 works by stimulating the pituitary gland through GHRH receptors, while Ipamorelin activates the ghrelin receptor (GHS-R) to trigger growth hormone release. Together, these peptides are studied for their combined ability to enhance growth hormone signaling through multiple pathways, resulting in a more comprehensive hormonal response.